Tempus Ai Cl A (TEM)

$76.33 +1.42 (1.90%)
Market Cap 13.16B
Revenue (ttm) 693.40M
Net Income (ttm) -705.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.79%
Debt to Equity Ratio 0.59
Volume 3,626,614
Avg Vol 6,450,426
Day's Range N/A - N/A
Shares Out 177.91M
Stochastic %K 66%
Beta 4.99
Analysts Sell
Price Target $90.00

Company Profile

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
__GoldingSteers
__GoldingSteers Dec. 4 at 9:35 PM
SNSE will SQUEEZE DON'T OVERLOOK IT!! $SNPS $CIFR $EOSE $TEM 1
0 · Reply
Iightning
Iightning Dec. 4 at 8:30 PM
1ightning® Premium Options Alert (Actionable) Ticker: $TEM Contract: Dec 19 $78C Entry: 3.90 Exit: 7.09 Return: +81.82% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Dec. 4 at 7:47 PM
$TEM
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 4:56 PM
$TEM AtomicAlerts® Scalp Alert Direction: LONG Entry: $77.53 TP1: $78.23 | TP2: $78.93 | TP3: $79.63 Stop Loss: $76.93 EMA9: 77.59 | EMA21: 77.57 RSI14: 64.07 | VWAP: 75.77 Paid Alerts: https://atomicalerts.com
0 · Reply
TheProphetOfProfit
TheProphetOfProfit Dec. 4 at 4:53 PM
$TEM bull flag breaking out on the daily today.
0 · Reply
SirGeorgetheBreathless
SirGeorgetheBreathless Dec. 4 at 3:48 PM
$TEM just like that- profit taken, steak dinner tonight!
0 · Reply
koditrump
koditrump Dec. 4 at 3:46 PM
$SOUN $RKLB $TSLA $TEM
0 · Reply
JasonCO
JasonCO Dec. 4 at 3:31 PM
$TEM 10,000 rocket emoji
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 3:23 PM
$TEM AtomicAlerts® Scalp Alert Direction: LONG Entry: $76.77 TP1: $77.47 | TP2: $78.17 | TP3: $78.87 Stop Loss: $76.17 EMA9: 76.17 | EMA21: 75.72 RSI14: 81.23 | VWAP: 74.87 Paid Alerts: https://atomicalerts.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 4 at 2:31 PM
Enter: $TEM Calls Strike Price: $75 Expiry Date: DEC 26 2025 Buy in Price: $4.80 - $6.70 Sell Price: $8.59 Profit : +79% (Turn every $1 into $1.79) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Latest News on TEM
Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 3, 2025, 12:53 PM EST - 1 day ago

Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Why Tempus AI Stock Soared This Week

Nov 28, 2025, 3:18 PM EST - 6 days ago

Why Tempus AI Stock Soared This Week

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 8:30 AM EST - 16 days ago

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Tempus AI: Opportunity To Build Position

Nov 15, 2025, 10:00 AM EST - 19 days ago

Tempus AI: Opportunity To Build Position

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Nov 14, 2025, 8:30 AM EST - 20 days ago

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Tempus AI, Inc. (TEM) Presents at Stifel 2025 Healthcare Conference Transcript

Nov 13, 2025, 12:11 PM EST - 21 days ago

Tempus AI, Inc. (TEM) Presents at Stifel 2025 Healthcare Conference Transcript

Tempus AI: Great Buying Opportunity On Recent Weakness

Nov 13, 2025, 9:59 AM EST - 21 days ago

Tempus AI: Great Buying Opportunity On Recent Weakness

Tempus AI: A Good Bet For The Future Of Health Care

Nov 12, 2025, 5:34 PM EST - 21 days ago

Tempus AI: A Good Bet For The Future Of Health Care

Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy

Nov 10, 2025, 9:55 PM EST - 23 days ago

Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy

Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says

Nov 5, 2025, 1:00 PM EST - 4 weeks ago

Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says

Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Nov 5, 2025, 8:30 AM EST - 4 weeks ago

Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

3 Growth Stocks to Invest $1,000 in Right Now

Nov 5, 2025, 5:25 AM EST - 4 weeks ago

3 Growth Stocks to Invest $1,000 in Right Now

NBIS VRT

Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 7:06 PM EST - 4 weeks ago

Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript

Tempus Reports Third Quarter 2025 Results

Nov 4, 2025, 4:01 PM EST - 4 weeks ago

Tempus Reports Third Quarter 2025 Results

Tempus to Participate in the Stifel 2025 Healthcare Conference

Oct 28, 2025, 8:30 AM EDT - 5 weeks ago

Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus to Report Third Quarter 2025 Financial Results on November 4

Oct 21, 2025, 8:30 AM EDT - 6 weeks ago

Tempus to Report Third Quarter 2025 Financial Results on November 4

Why Tempus AI Stock Raced More Than 5% Higher Today

Oct 20, 2025, 6:36 PM EDT - 6 weeks ago

Why Tempus AI Stock Raced More Than 5% Higher Today

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

Oct 20, 2025, 9:00 AM EDT - 6 weeks ago

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Oct 16, 2025, 8:30 AM EDT - 7 weeks ago

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

WHWK

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Oct 15, 2025, 8:30 AM EDT - 7 weeks ago

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Oct 9, 2025, 8:30 AM EDT - 2 months ago

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall

Oct 9, 2025, 8:24 AM EDT - 2 months ago

Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall

Why Tempus AI Stock Was Motoring Higher This Week

Oct 3, 2025, 5:30 AM EDT - 2 months ago

Why Tempus AI Stock Was Motoring Higher This Week

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Oct 1, 2025, 12:24 PM EDT - 2 months ago

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Why Tempus AI Stock Is Plunging This Week

Sep 25, 2025, 6:53 PM EDT - 2 months ago

Why Tempus AI Stock Is Plunging This Week

Overlooked Stock: TEM Taps All-Time High on FDA Clearance

Sep 22, 2025, 4:30 PM EDT - 2 months ago

Overlooked Stock: TEM Taps All-Time High on FDA Clearance

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Sep 22, 2025, 8:30 AM EDT - 2 months ago

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

Sep 15, 2025, 8:00 AM EDT - 2 months ago

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

Tempus AI stock is cheap as Murrey Math Lines points to more gains

Sep 12, 2025, 1:09 PM EDT - 2 months ago

Tempus AI stock is cheap as Murrey Math Lines points to more gains

Tempus AI: Is TEM Stock A 10x Growth Story?

Sep 12, 2025, 10:05 AM EDT - 2 months ago

Tempus AI: Is TEM Stock A 10x Growth Story?

Why Tempus AI Stock Soared Nearly 14% Higher Today

Sep 11, 2025, 6:26 PM EDT - 2 months ago

Why Tempus AI Stock Soared Nearly 14% Higher Today

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Sep 11, 2025, 1:58 PM EDT - 3 months ago

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

Sep 11, 2025, 8:30 AM EDT - 3 months ago

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

Why Are Stock Market Investors Talking About TempusAI Stock?

Sep 10, 2025, 11:05 AM EDT - 3 months ago

Why Are Stock Market Investors Talking About TempusAI Stock?

Stock Market Investors Want to Know: What's Going on With TempusAI Stock?

Sep 10, 2025, 10:43 AM EDT - 3 months ago

Stock Market Investors Want to Know: What's Going on With TempusAI Stock?

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

Sep 9, 2025, 8:30 AM EDT - 3 months ago

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

Tempus AI, Inc. (TEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 4:25 PM EDT - 3 months ago

Tempus AI, Inc. (TEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

After An Odd Start, Tempus AI Is Making A Beeline To The Good End Of The AI Rainbow

Sep 8, 2025, 10:58 AM EDT - 3 months ago

After An Odd Start, Tempus AI Is Making A Beeline To The Good End Of The AI Rainbow

Tempus AI: Evolving To Data Infrastructure And Monetization Options Platform

Sep 8, 2025, 4:43 AM EDT - 3 months ago

Tempus AI: Evolving To Data Infrastructure And Monetization Options Platform

Tempus AI: Strategic AI Advancements In Precision Oncology With Solid Stock Upside Potential

Sep 8, 2025, 2:35 AM EDT - 3 months ago

Tempus AI: Strategic AI Advancements In Precision Oncology With Solid Stock Upside Potential

Tempus AI: Expansive Opportunity As Healthcare Becomes More Heavily Scrutinized

Sep 4, 2025, 2:33 PM EDT - 3 months ago

Tempus AI: Expansive Opportunity As Healthcare Becomes More Heavily Scrutinized

Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR Platform

Sep 4, 2025, 8:30 AM EDT - 3 months ago

Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR Platform

Tempus to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference

Sep 3, 2025, 4:01 PM EDT - 3 months ago

Tempus to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference

The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode

Aug 23, 2025, 4:00 AM EDT - 3 months ago

The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode

RXRX

Tempus Announces the Acquisition of Paige

Aug 22, 2025, 9:20 AM EDT - 3 months ago

Tempus Announces the Acquisition of Paige

Tempus AI: TEM Stock To $130?

Aug 18, 2025, 9:24 AM EDT - 3 months ago

Tempus AI: TEM Stock To $130?

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

Aug 14, 2025, 1:02 PM EDT - 4 months ago

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

AMD ARKF ARKG ARKK ARKQ ARKW ARKX

Tempus AI Stock: Is It A Buy Following Guidance Raise?

Aug 12, 2025, 7:45 AM EDT - 4 months ago

Tempus AI Stock: Is It A Buy Following Guidance Raise?

TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm

Aug 12, 2025, 4:42 AM EDT - 4 months ago

TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm

__GoldingSteers
__GoldingSteers Dec. 4 at 9:35 PM
SNSE will SQUEEZE DON'T OVERLOOK IT!! $SNPS $CIFR $EOSE $TEM 1
0 · Reply
Iightning
Iightning Dec. 4 at 8:30 PM
1ightning® Premium Options Alert (Actionable) Ticker: $TEM Contract: Dec 19 $78C Entry: 3.90 Exit: 7.09 Return: +81.82% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Dec. 4 at 7:47 PM
$TEM
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 4:56 PM
$TEM AtomicAlerts® Scalp Alert Direction: LONG Entry: $77.53 TP1: $78.23 | TP2: $78.93 | TP3: $79.63 Stop Loss: $76.93 EMA9: 77.59 | EMA21: 77.57 RSI14: 64.07 | VWAP: 75.77 Paid Alerts: https://atomicalerts.com
0 · Reply
TheProphetOfProfit
TheProphetOfProfit Dec. 4 at 4:53 PM
$TEM bull flag breaking out on the daily today.
0 · Reply
SirGeorgetheBreathless
SirGeorgetheBreathless Dec. 4 at 3:48 PM
$TEM just like that- profit taken, steak dinner tonight!
0 · Reply
koditrump
koditrump Dec. 4 at 3:46 PM
$SOUN $RKLB $TSLA $TEM
0 · Reply
JasonCO
JasonCO Dec. 4 at 3:31 PM
$TEM 10,000 rocket emoji
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 3:23 PM
$TEM AtomicAlerts® Scalp Alert Direction: LONG Entry: $76.77 TP1: $77.47 | TP2: $78.17 | TP3: $78.87 Stop Loss: $76.17 EMA9: 76.17 | EMA21: 75.72 RSI14: 81.23 | VWAP: 74.87 Paid Alerts: https://atomicalerts.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 4 at 2:31 PM
Enter: $TEM Calls Strike Price: $75 Expiry Date: DEC 26 2025 Buy in Price: $4.80 - $6.70 Sell Price: $8.59 Profit : +79% (Turn every $1 into $1.79) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Benpsf
Benpsf Dec. 4 at 2:18 PM
$TEM Tempus AI – Pushing Up From the 50% Retracement Price Target: $91.28 Tempus is trending upward after bouncing from the 50% retracement zone and has now cleared the 0.618 Fibonacci level. The next objective is $91.28, which lines up with a key prior resistance area.
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 1:46 PM
$TEM AtomicAlerts® Scalp Alert Direction: LONG Entry: $74.90 TP1: $75.60 | TP2: $76.30 | TP3: $77.00 Stop Loss: $74.30 EMA9: 75.0 | EMA21: 75.0 RSI14: 40.24 | VWAP: 74.84 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 12:12 PM
$TEM AtomicAlerts® Scalp Alert Direction: LONG Entry: $74.90 TP1: $75.60 | TP2: $76.30 | TP3: $77.00 Stop Loss: $74.30 EMA9: 75.0 | EMA21: 75.0 RSI14: 40.24 | VWAP: 74.84 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 10:57 AM
$TEM AtomicAlerts® Scalp Alert Direction: LONG Entry: $74.90 TP1: $75.60 | TP2: $76.30 | TP3: $77.00 Stop Loss: $74.30 EMA9: 75.0 | EMA21: 75.0 RSI14: 40.24 | VWAP: 74.84 Paid Alerts: https://atomicalerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Dec. 4 at 10:01 AM
💎 LiquidTheta® Live Actionable Trade Asset: $TEM Contracts: $TEM January 15, 2027 $75 Calls Scale in: $21.47- $26.24 Scale out: $83.48-$143.10 Profit Potential : 324% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 6:50 AM
Hedge Alert Live - Protect Your Portfolio Contract: $TEM $74.00 Put · DEC 12, 2025 Exp Entry Price: $2.70 - $2.90 Exit Price Target: $6.08 Profit Margin: +125% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Iightning
Iightning Dec. 4 at 4:12 AM
1ightning® Premium Options Alert (Actionable) Ticker: $TEM Contract: Dec 19 $75C Entry: 4.45 Exit: 5.70 Return: +28.00% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
JasonCO
JasonCO Dec. 3 at 8:57 PM
$TEM you don’t have enough
1 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 7:10 PM
$TEM Current Stock Price: $74.47 Contracts to trade: $75 TEM Dec 05 2025 Call Entry: $1.80 Exit: $3.58 ROI: 99% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Ryanmac8688
Ryanmac8688 Dec. 3 at 3:38 PM
$TEM 🔥🆙🚀
0 · Reply
Ryanmac8688
Ryanmac8688 Dec. 3 at 3:38 PM
$TEM
0 · Reply
JasonCO
JasonCO Dec. 3 at 3:32 PM
$TEM
0 · Reply